FDA Authorizes KMT2A FISH Test as Companion Diagnostic for Acute Leukemia Therapy
The breakapart probe detects gene rearrangements in acute leukemia patients to identify candidates for menin inhibitor therapy.
Read MorePosted by CLP Edit Staff | Sep 23, 2025 | Leukemia |
The breakapart probe detects gene rearrangements in acute leukemia patients to identify candidates for menin inhibitor therapy.
Read MorePosted by CLP Edit Staff | Sep 18, 2025 | Sequencing Systems |
The expanded testing capabilities leverage long-read sequencing technology to detect disorders such as Fragile X syndrome, adult neurological conditions, certain ataxias, and more.
Read MorePosted by CLP Edit Staff | Sep 12, 2025 | Hematology & Serology |
The expanded menu brings the number of tests to 67, with samples requiring only a pea-sized drop of blood collected from a fingertip.
Read MorePosted by CLP Edit Staff | Sep 12, 2025 | Hematology & Serology |
Three-year PERIBLOOD study will evaluate single-cell RNA sequencing as minimally invasive alternative to bone marrow aspiration for blood disorder diagnosis.
Read MorePosted by CLP Edit Staff | Sep 10, 2025 | Sequencing Systems |
Study shows Foresight CLARITY demonstrated 68% pre-operative and 38% post-operative MRD detection rates in stage I lung cancer patients.
Read More